Posts Tagged ‘drug

October 28, 2019
Our Take: Biogen’s aducanumab gets a second life
Read More
September 09, 2019
Our Take: Judge rules against Johnson & Johnson in landmark opioid case
Read More
August 12, 2019
Our Take: FDA threatens legal action against Novartis over faulty data used in application for $2.1 million gene therapy
Read More
August 12, 2019
Episode 65: Our Take, August 12, 2019
Read More
August 05, 2019
Our Take: CMS gears up for fiscal year 2020
Read More
July 29, 2019
Episode 63: Our Take, July 29, 2019
Read More
June 17, 2019
Episode 55: Our Take, June 17, 2019
Read More
June 13, 2019
Episode 54: Building an in-house specialty pharmacy within an IDN with Brett McClain
Read More
June 10, 2019
Episode 53: Our Take, June 10, 2019
Read More
June 03, 2019
Our Take: Novartis sets $2.1M price for spinal muscular atrophy gene therapy, watchdog agrees
Read More
May 30, 2019
Episode 51: Three Dartmouth Guys Talk Health Care
Read More
May 23, 2019
Episode 50: Our Take May–Part 2
Read More
February 19, 2019
Our Take: FDA panels recommend approval for novel depression treatment
Read More
December 10, 2018
Our Take: CVS’ new PBM model focuses on net cost pricing for greater predictability
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Copyright © 2025 Darwin Research Group Inc.

Stay Connected